| Name | Title | Contact Details |
|---|
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.
U M W A Health and Retirement Fund is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthLinx Executive Search is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Laxai is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Hospital Service Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.